Eisai
4523.T
#2011
Rank
โ‚น702.58 B
Marketcap
โ‚น2,462
Share price
-1.22%
Change (1 day)
-29.13%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): โ‚น179.60

According to Eisai's latest financial reports the company's current EPS (TTM) is โ‚น189.39. In 2022 the company made an earnings per share (EPS) of โ‚น139.03 a decrease over its 2021 EPS that were of โ‚น617.25.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น179.6029.18%
2022โ‚น139.03-77.48%
2021โ‚น617.25-41.88%
2020โ‚น1,062-0.94%
2019โ‚น1,07252.59%
2018โ‚น702.57124.17%
2017โ‚น313.41-49.42%
2016โ‚น619.6937.08%
2015โ‚น452.07-11.75%
2014โ‚น512.24-3.23%
2013โ‚น529.34-18.56%
2012โ‚น650.01-15.51%
2011โ‚น769.36-3.75%
2010โ‚น799.37-1.36%
2009โ‚น810.38